Single-cell Raman spectroscopy of irradiated tumour cells

dc.contributor.authorMatthews, Quinn
dc.contributor.supervisorJirasek, Andrew
dc.date.accessioned2011-09-30T17:31:34Z
dc.date.available2011-09-30T17:31:34Z
dc.date.copyright2011en_US
dc.date.issued2011-09-30
dc.degree.departmentDept. of Physics and Astronomyen_US
dc.degree.levelDoctor of Philosophy Ph.D.en_US
dc.description.abstractThis work describes the development and application of a novel combination of single-cell Raman spectroscopy (RS), automated data processing, and principal component analysis (PCA) for investigating radiation induced biochemical responses in human tumour cells. The developed techniques are first validated for the analysis of large data sets (~200 spectra) obtained from single cells. The effectiveness and robustness of the automated data processing methods is demonstrated, and potential pitfalls that may arise during the implementation of such methods are identified. The techniques are first applied to investigate the inherent sources of spectral variability between single cells of a human prostate tumour cell line (DU145) cultured {\it in vitro}. PCA is used to identify spectral differences that correlate with cell cycle progression and the changing confluency of a cell culture during the first 3-4 days after sub-culturing. Spectral variability arising from cell cycle progression is (i) expressed as varying intensities of protein and nucleic acid features relative to lipid features, (ii) well correlated with known biochemical changes in cells as they progress through the cell cycle, and (iii) shown to be the most significant source of inherent spectral variability between cells. This characterization provides a foundation for interpreting spectral variability in subsequent studies. The techniques are then applied to study the effects of ionizing radiation on human tumour cells. DU145 cells are cultured in vitro and irradiated to doses between 15 and 50 Gy with single fractions of 6 MV photons from a medical linear accelerator. Raman spectra are acquired from irradiated and unirradiated cells, up to 5 days post-irradiation. PCA is used to distinguish radiation induced spectral changes from inherent sources of spectral variability, such as those arising from cell cycle. Radiation induced spectral changes are found to correlate with both the irradiated dose and the incubation time post-irradiation, and to arise from biochemical differences in lipids, nucleic acids, amino acids, and conformational protein structures between irradiated and unirradiated cells. This study is the first use of RS to observe radiation induced biochemical effects in single cells, and is the first use of vibrational spectroscopy to observe such effects independent from cell cycle or cell death related processes. The same methods are then applied to a panel of human tumour cell lines, derived from prostate (DU145, PC3, LNCaP and PacMet), breast (MDA-MB-231 and MCF7) and lung (H460), which vary by p53 gene status and intrinsic radiosensitivity. One radiation induced PCA component is detected for each cell line by statistically significant changes in the PCA score distributions for irradiated samples, as compared to unirradiated samples, in the first 24 to 72 hours post-irradiation. These RS response signatures arise from radiation induced changes in cellular concentrations of aromatic amino acids, conformational protein structures, and certain nucleic acid and lipid functional groups. Correlation analysis between the radiation induced PCA components separates the cell lines into three unique RS response categories: R1 (H460, MCF7 and PacMet), R2 (MDA-MB-231 and PC3), and R3 (DU145 and LNCaP). These RS categories partially segregate according to radiosensitivity; the R1 and R2 cell lines are radioresistant and the R3 cell lines are radiosensitive (PacMet radiosensitivity (R1) unknown). The R1 and R2 cell lines further segregate according to p53 gene status, corroborated by cell cycle analysis post-irradiation. Preliminary results obtained from a mouse prostate tumour cell line (TRAMP-C2), irradiated both in vitro and in vivo, indicate that RS signatures of radiation response may also be detectable from tumour cells obtained from an in vivo system during radiation therapy treatment. These results indicate the potential for future RS studies designed to investigate, monitor, or predict radiation response.en_US
dc.description.scholarlevelGraduateen_US
dc.identifier.bibliographicCitationQ Matthews, A Jirasek, J Lum, X Duan, and AG Brolo. Variability in Raman spectra of single human tumor cells cultured in vitro: correlation with cell cycle and culture confluency. Appl. Spectrosc., 64(8):871–87, 2010. Publisher - Society for Applied Spectroscopy.en_US
dc.identifier.bibliographicCitationQ Matthews, AG Brolo, J Lum, X Duan, and A Jirasek. Raman spectroscopy of single human tumour cells exposed to ionizing radiation in vitro. Phys. Med. Biol., 56(1):19–38, 2011. Publisher - IOP Publishing.en_US
dc.identifier.urihttp://hdl.handle.net/1828/3584
dc.language.isoenen_US
dc.rights.tempAvailable to the World Wide Weben_US
dc.subjectMedical physicsen_US
dc.subjectRadiation therapyen_US
dc.subjectRaman spectroscopyen_US
dc.subjectRadiobiologyen_US
dc.subjectCancer therapyen_US
dc.subjecttumoren_US
dc.titleSingle-cell Raman spectroscopy of irradiated tumour cellsen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Matthews_Quinn_PhD_2011.pdf
Size:
16.85 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description: